1. Home
  2. IMAB vs FVCB Comparison

IMAB vs FVCB Comparison

Compare IMAB & FVCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMAB
  • FVCB
  • Stock Information
  • Founded
  • IMAB 2014
  • FVCB 2007
  • Country
  • IMAB United States
  • FVCB United States
  • Employees
  • IMAB N/A
  • FVCB N/A
  • Industry
  • IMAB Biotechnology: Pharmaceutical Preparations
  • FVCB Major Banks
  • Sector
  • IMAB Health Care
  • FVCB Finance
  • Exchange
  • IMAB Nasdaq
  • FVCB Nasdaq
  • Market Cap
  • IMAB 200.9M
  • FVCB 204.0M
  • IPO Year
  • IMAB 2020
  • FVCB N/A
  • Fundamental
  • Price
  • IMAB $4.87
  • FVCB $12.83
  • Analyst Decision
  • IMAB Strong Buy
  • FVCB Buy
  • Analyst Count
  • IMAB 3
  • FVCB 1
  • Target Price
  • IMAB $6.33
  • FVCB $16.00
  • AVG Volume (30 Days)
  • IMAB 4.2M
  • FVCB 35.8K
  • Earning Date
  • IMAB 05-15-2025
  • FVCB 07-22-2025
  • Dividend Yield
  • IMAB N/A
  • FVCB 1.87%
  • EPS Growth
  • IMAB N/A
  • FVCB 359.39
  • EPS
  • IMAB N/A
  • FVCB 1.11
  • Revenue
  • IMAB N/A
  • FVCB $62,780,000.00
  • Revenue This Year
  • IMAB N/A
  • FVCB $12.99
  • Revenue Next Year
  • IMAB N/A
  • FVCB $7.26
  • P/E Ratio
  • IMAB N/A
  • FVCB $11.57
  • Revenue Growth
  • IMAB N/A
  • FVCB 40.73
  • 52 Week Low
  • IMAB $0.60
  • FVCB $9.49
  • 52 Week High
  • IMAB $5.90
  • FVCB $14.50
  • Technical
  • Relative Strength Index (RSI)
  • IMAB 75.47
  • FVCB 51.59
  • Support Level
  • IMAB $3.30
  • FVCB $12.25
  • Resistance Level
  • IMAB $3.94
  • FVCB $13.39
  • Average True Range (ATR)
  • IMAB 0.58
  • FVCB 0.37
  • MACD
  • IMAB 0.23
  • FVCB -0.01
  • Stochastic Oscillator
  • IMAB 76.12
  • FVCB 50.88

About IMAB I-MAB

I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).

About FVCB FVCBankcorp Inc.

FVCBankcorp Inc is a registered bank holding company. It operates through the sole subsidiary, FVCbank which is a community-oriented, locally-owned, and managed commercial bank. It offers commercial banking services to small and medium-sized businesses, professionals, non-profit organizations and associations, and investors. It also provides retail banking services to accommodate the individual needs of both corporate customers as well as the communities it serves. The bank provides other facilities such as online banking, mobile banking, remote deposit service, and lending products, among others. Its primary source of revenue is the net interest income.

Share on Social Networks: